AB001 -A new transdermal patch for musculoskeletal

AB001 -A new transdermal patch for musculoskeletal
Product Description

A third generation topical patch for the management of pain and inflammation. - Long half life; once daily dosage with relatively shorter administration period provides efficacy with less skin irritation/inflammation. - Patch is non-hydrogel, alcohol-free formulation.- Patch matrix formulation is only 0.2mm thick, flexible in large and small areas.Contact us for more information.

Read more Show less

Frontier Biotechnologies Inc.

  • CN
  • 2017
    On CPHI since
View company profile
Categories
more categories Show less
Specifications
  • Selling Points
    Price; Product Features; Product Performance; Quality Service; Reputation
  • Supplied from
    China
  • Measured In
    piece
More specifications Fewer specifications
Sales Markets
Show more Show less

Frontier Biotechnologies Inc.

  • CN
  • 2017
    On CPHI since
View company profile

More Products from Frontier Biotechnologies Inc. (2)

  • Albuvirtide for injection - A Long-acting HIV Fusion Inhibitor

    Product Albuvirtide for injection - A Long-acting HIV Fusion Inhibitor

    The world’s first long acting HIV fusion inhibitor. An amino acid synthesized peptide, lyophilized powder for injection with shelf life 24 months. The API should be stored and transported at -20C, and the finished product should be stored and transported at 2-8C. ALBUVIRTIDE only need to be ad...
  • 3BNC117 - A Novel Broad-spectrum HIV Neutralizing Antibody

    Product 3BNC117 - A Novel Broad-spectrum HIV Neutralizing Antibody

    3BNC117 is one of the most effective broad-spectrum HIV neutralizing antibodies. Several phase 1 and phase 2 clinical trials have been conducted in the US, showing 3BNC117 not only blocks viral replication like other AIDS drugs, but also induces immune response to HIV and HIV-infected cells. Combining 3...